EU Trade Group Backs FDA's $300M Generics Fees Plan
A European chemical trade group on Friday became the last of three major industry groups to ratify a proposal that calls for generic-drug makers to pay $299 million in annual fees to the U.S. Food and...To view the full article, register now.
Already a subscriber? Click here to view full article